BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9389053)

  • 21. [The alteration of MTS1 gene in precancerous lesions and squamous cell carcinoma of oral mucosa].
    Wang WX; Sun SZ; Yang PS; Ma BL; Long Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Sep; 38(5):361-3. PubMed ID: 14680586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infrequent p53 mutations in patients with areca quid chewing-associated oral squamous cell carcinomas in Taiwan.
    Kuo MY; Huang JS; Hsu HC; Chiang CP; Kok SH; Kuo YS; Hong CY
    J Oral Pathol Med; 1999 May; 28(5):221-5. PubMed ID: 10226945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of point mutation of p53 gene by silver staining PCR-SSCP in paraffin-embedded malignant fibrous histiocytoma].
    Li J; Yang G; Li G
    Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):13-5. PubMed ID: 8732103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
    Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
    Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 expression and p53 gene mutation in oral cancer and dysplasia.
    Rowley H; Sherrington P; Helliwell TR; Kinsella A; Jones AS
    Otolaryngol Head Neck Surg; 1998 Jan; 118(1):115-23. PubMed ID: 9450841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 aberrations in oral submucous fibrosis and oral squamous cell carcinoma detected by immunocytochemistry and PCR-SSCP.
    Trivedy C; Warnakulasuriya KA; Tavassoli M; Steingrimsdottir H; Penhallow J; Maher R; Johnson NW
    J Oral Pathol Med; 1998 Feb; 27(2):72-7. PubMed ID: 9526733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
    Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
    Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
    Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
    Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific p53 mutations predict poor prognosis in oral squamous cell carcinoma.
    Yamazaki Y; Chiba I; Hirai A; Sugiura C; Notani K; Kashiwazaki H; Tei K; Totsuka Y; Fukuda H
    Oral Oncol; 2003 Feb; 39(2):163-9. PubMed ID: 12509970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
    Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
    Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Analysis of p53 gene mutation in esophageal exfoliative cells].
    Kou YL; Zhang JR; Zhou Q; Zhao YF; Chen GD
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):349-52. PubMed ID: 15312345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India.
    Saranath D; Tandle AT; Teni TR; Dedhia PM; Borges AM; Parikh D; Sanghavi V; Mehta AR
    Oral Oncol; 1999 May; 35(3):242-50. PubMed ID: 10621843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
    Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
    Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence of multi-step oncogenesis of oral squamous cell carcinoma.
    Imai FL; Uzawa K; Shiiba M; Watanabe T; Miya T; Kubosawa H; Kondo Y; Tanzawa H
    Oncol Rep; 1998; 5(6):1489-91. PubMed ID: 9769393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radioresistance in oral squamous cell carcinoma with p53 DNA contact mutation.
    Yamazaki Y; Chiba I; Hirai A; Notani K; Kashiwazaki H; Tei K; Totsuka Y; Iizuka T; Kohgo T; Fukuda H
    Am J Clin Oncol; 2003 Oct; 26(5):e124-9. PubMed ID: 14528086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-deletion mutation of the p53 gene at exon 4 of codon 63 in the saliva of oral squamous cell carcinoma in central India: a preliminary study.
    Mewara A; Gadbail AR; Patil S; Chaudhary M; Chavhan SD
    J Investig Clin Dent; 2010 Nov; 1(2):108-13. PubMed ID: 25427266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of p53 mutant nuclear phosphoprotein in oral carcinoma and potentially malignant oral lesions.
    Warnakulasuriya KA; Johnson NW
    J Oral Pathol Med; 1992 Oct; 21(9):404-8. PubMed ID: 1432735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers.
    Nelson MA; Einspahr JG; Alberts DS; Balfour CA; Wymer JA; Welch KL; Salasche SJ; Bangert JL; Grogan TM; Bozzo PO
    Cancer Lett; 1994 Sep; 85(1):23-9. PubMed ID: 7923098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of antigen retrieval for immunohistochemical detection of p53 over-expression in malignant and benign oral mucosa: a cautionary note.
    Dowell SP; Ogden GR
    J Oral Pathol Med; 1996 Feb; 25(2):60-4. PubMed ID: 8667257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p53 protein expression in sequential biopsies of oral dysplasias and in situ carcinomas.
    Regezi JA; Zarbo RJ; Regev E; Pisanty S; Silverman S; Gazit D
    J Oral Pathol Med; 1995 Jan; 24(1):18-22. PubMed ID: 7722917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.